Two Sigma Advisers’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-94,000
Closed -$698K 2099
2025
Q4
$698K Buy
94,000
+19,200
+26% +$132K ﹤0.01% 1656
2025
Q3
$508K Buy
74,800
+27,300
+57% +$185K ﹤0.01% 1759
2025
Q2
$328K Sell
47,500
-26,900
-36% -$183K ﹤0.01% 1923
2025
Q1
$542K Buy
74,400
+60,700
+443% +$477K ﹤0.01% 1741
2024
Q4
$110K Sell
13,700
-35,100
-72% -$305K ﹤0.01% 2208
2024
Q3
$358K Sell
48,800
-16,600
-25% -$119K ﹤0.01% 1844
2024
Q2
$428K Sell
65,400
-22,200
-25% -$167K ﹤0.01% 1946
2024
Q1
$826K Sell
87,600
-3,200
-4% -$27.4K ﹤0.01% 1667
2023
Q4
$713K Sell
90,800
-24,700
-21% -$179K ﹤0.01% 1780
2023
Q3
$777K Sell
115,500
-7,400
-6% -$60.6K ﹤0.01% 1625
2023
Q2
$1.2M Buy
122,900
+16,200
+15% +$165K ﹤0.01% 1461
2023
Q1
$1.03M Buy
106,700
+43,000
+68% +$375K ﹤0.01% 1615
2022
Q4
$482K Buy
63,700
+19,000
+43% +$129K ﹤0.01% 1893
2022
Q3
$268K Buy
+44,700
New +$287K ﹤0.01% 2095
2021
Q3
Sell
-33,400
Closed -$239K 2689
2021
Q2
$239K Sell
33,400
-66,200
-66% -$573K ﹤0.01% 2220
2021
Q1
$1.01M Sell
99,600
-4,400
-4% -$41.4K ﹤0.01% 1645
2020
Q4
$807K Sell
104,000
-28,100
-21% -$247K ﹤0.01% 1671
2020
Q3
$1.14M Sell
132,100
-24,200
-15% -$244K ﹤0.01% 1445
2020
Q2
$1.5M Buy
156,300
+125,600
+409% +$976K ﹤0.01% 1366
2020
Q1
$146K Sell
30,700
-26,500
-46% -$131K ﹤0.01% 2247
2019
Q4
$355K Buy
+57,200
New +$397K ﹤0.01% 2010

Other funds holding VMD

Two Sigma Advisers's VMD Position: Q1 2026 in Review

Two Sigma Advisers sold out of Viemed Healthcare (VMD) in Q1 2026, closing a stake of 94,000 shares — an estimated $698K sold.

Two Sigma Advisers first reported a position in VMD in Q4 2019 and held it in 21 quarters. The position peaked at $1.5M in Q2 2020. 150 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • Two Sigma Advisers reported no remaining Viemed Healthcare position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 94,000 Viemed Healthcare shares in Q1 2026, an estimated $698K.
  • Two Sigma Advisers first reported a position in Viemed Healthcare in Q4 2019 and held it in 21 quarters.
  • Two Sigma Advisers's Viemed Healthcare position peaked at $1.5M in Q2 2020.
  • 150 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.